# A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants

> **NCT06751017** · PHASE1 · COMPLETED · sponsor: **Shionogi** · enrollment: 16 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** S-892216
- **DRUG:** Carbamazepine

## Key facts

- **NCT ID:** NCT06751017
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-17
- **Primary completion:** 2025-02-24
- **Final completion:** 2025-02-24
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06751017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06751017, "A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06751017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*